| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.0037 | 1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |